Clinical Trials Logo

Clinical Trial Summary

Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation: An AcQMap Substrate Characterization Study (PLASZMA)


Clinical Trial Description

The AcQMap Imaging and Mapping System® is intended for use in patients for whom electrophysiology procedures have been prescribed. When used with the AcQMap Catheters, the AcQMap System is intended to be used to reconstruct the selected chamber from ultrasound data for purposes of visualizing the chamber anatomy and displaying electrical impulses as either charge density-based or voltage-based maps of complex arrhythmias that may be difficult to identify using conventional mapping systems alone. AND When used with specified Patient Electrodes, the AcQMap System is intended to display the position of the AcQMap Catheters and conventional electrophysiology (EP) catheters in the heart. OR When used with conventional electrophysiology catheters, the AcQMap System provides information about the electrical activity of the heart and about catheter location during the procedure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04512794
Study type Interventional
Source Acutus Medical
Contact
Status Withdrawn
Phase N/A
Start date September 1, 2022
Completion date December 1, 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT04429464 - AcQBlate Force Confirmatory Study for Atrial Arrhythmias N/A
Not yet recruiting NCT06452589 - The Field PULSE Study N/A